Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
False information undermines health and exacerbates disabilities. Constitutional rights to free speech come with responsibilities. Clinicians and citizens have duties to counter false health information.
AMA J Ethics. 2021;23(5):E432-433. doi:
10.1001/amajethics.2021.432.
The author believes the AMA's Council on Ethical and Judicial Affairs should collaborate with academic physicians to create clear professional standards for the field of medicine.
The threat of bioterrorism in the form of aerosolized smallpox is real, and policy is needed to clarify the risk of disease to the public and recommendations on vaccination.
The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.